Treatment of AL amyloidosis with high dose therapy and autologous stem cell transplantation

Meletios A Dimopoulos

doi:10.1080/10428190600647509

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2002

High Dose Therapy with Autologous Stem Cell Transplantation for Solitary Bone Plasmacytoma Complicated by Local Relapse or Isolated Distant Recurrence

Meletios A Dimopoulos, Christos Papadimitriou, Athanassios Anagnostopoulos, Dimitrios Mitsibounas, Jean‐Paul Fermand

Letter2005

Autologous Stem Cell and Kidney Transplantation for Primary Amyloidosis Associated with ESRD: Which Should Come First?

Giampaolo Merlini, Giuseppe Remuzzi

Article2007

High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial

Christos Papadimitriou, Urania Dafni, Αchilles Anagnostopoulos, G. Vlachos, Zannis Voulgaris, Alexandros Rodolakis, Gerasimos Aravantinos, Aristotelis Bamias, George Bozas, Evangelos Kiosses, G.-M. Gourgoulis, Eleni Efstathiou, Meletios A Dimopoulos

Article2000

Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent

Athanasios Zomas, Nicolaos Anagnostopoulos, Meletios A Dimopoulos

Article2012

A Risk-Adapted Protocol for Delayed Administration of Filgrastim After High-Dose Chemotherapy and Autologous Stem Cell Transplantation

Amit Khot, Michael Dickinson, Kerrie Stokes, Simon J. Harrison, Kate Burbury, Shaun Fleming, Dominic Wall, Peter Gambell, H. Miles Prince, John F. Seymour, David Ritchie